Lilly operates in India through three business entities as well as has a significant presence through CSR partnerships as explained below.
Since its inception in India in 1993, Eli Lilly and Company (India) Pvt. Ltd. has been committed to developing and marketing pharmaceutical products to treat diabetes, lung cancer, osteoporosis and growth-hormone deficiency. Lilly India affiliate also comprises operations in neighboring countries of Nepal, Bangladesh and Sri Lanka.
Elanco, an animal health division of Lilly, was incorporated in 2014 in Gurgaon. Elanco India’s corporate office is in Mumbai. Lilly completed the acquisition of Novartis Animal Health in India in the beginning of 2016. The company is committed to the animal health industry and will continue seeking opportunities to deliver greater innovation and value to the customers.
For any further queries please write to :email@example.com or call +91 – 22-66156703
Lilly Capability Center India: Lilly opened the Lilly Capability Center India (LCCI) in Bangalore in January 2016. This center allows Lilly to take advantage of unique drug development capabilities found in India. Bangalore has been strategically chosen as a location for this center due to its concentration of research and development, electronics and software production companies.
Lilly unites caring with discovery to make life better for people around the world. Our work in India encompasses partnerships in MDR TB, Diabetes and Hypertension, as well as community volunteering projects through Global Day of Service, Connecting Hearts Abroad and a non formal education center called STEP UP. To find out more click on our CSR page.